(Q39857246)

English

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

scientific article published on June 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis (English)

1 reference

Europe PubMed Central

15 September 2017

cystic fibrosis

0 references

Pseudomonas aeruginosa

0 references

author name string

Scribner RK

1

1 reference

Europe PubMed Central

15 September 2017

Marks MI

2

1 reference

Europe PubMed Central

15 September 2017

Weber AH

3

1 reference

Europe PubMed Central

15 September 2017

Tarpay MM

4

1 reference

Europe PubMed Central

15 September 2017

Welch DF

5

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 June 1982

1 reference

Europe PubMed Central

15 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

15 September 2017

21

1 reference

Europe PubMed Central

15 September 2017

6

1 reference

Europe PubMed Central

15 September 2017

939-943

1 reference

Europe PubMed Central

15 September 2017

GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

Bronchial Secretion Levels of Amikacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

Comparative Study of Anti-Pseudomonas Activity of Azlocillin, Mezlocillin, and Ticarcillin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

In Vitro Activity of Piperacillin Compared with That of Carbenicillin, Ticarcillin, Ampicillin, Cephalothin, and Cefamandole Against Pseudomonas aeruginosa and Enterobacteriaceae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

22 September 2017

The Concentration of Tobramycin in Bronchial Secretions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

25 September 2017

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182049

25 September 2017

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/6810757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/6810757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/6810757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the excretion of azlocillin with bronchial secretion in children (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6810757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ticarcillin vs carbenicillin: Clinical pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/6810757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.21.6.939

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39857246&oldid=2091602627"